Peter E. Stassen

Peter has considerable experience with the regulatory side of M&A processes, and particularly with European, Danish, and multi-jurisdictional merger control matters. Peter has led a number of high-profile merger control processes involving businesses within a range of complex industries (including biotech, financial services, aviation, infrastructure, energy, and IT services), including several processes involving the design of remedy packages. Peter is particularly well-versed in providing strategic and deal certainty analyses of prospective transactions, is regularly advising on foreseeing and handling call-in risks, and also advises on all other transaction-related competition law issues, including how to handle the practical challenges associated with integration planning. As part of his regulatory practice, Peter also advises on Foreign Direct Investment (FDI) and Foreign Subsidies Regulation (FSR) issues, and has experience with handling state aid law considerations related to transactions involving public authorities and public undertakings.

Peter also regularly advises on matters related to abuse of dominance, including how to organise distribution systems and agreements to avoid pricing and discrimination abuse. He has extensive experience in public procurement law, particularly in the medical and pharmaceutical industries, as well as large-scale infrastructure and energy projects.

Peter is admitted to appear before the High Courts of Denmark, and in 2021 held an interim judgeship with the High Court of Eastern Denmark. Peter is also an experienced lecturer, having served as an external lecturer at King's College London from 2017–2020.

Peter believes that in an increasingly complex regulatory scene, in order to truly create value for the client in large transactional projects three things are key: Teamwork, recognising the need for cross-disciplinarity (for instance, involving our in-house competition economics experts or our M&A colleagues), and understanding the client's core commercial and industry-specific challenges.

Selected cases 

• Advised Novonesis on largest ever Danish merger with Chr. Hansen
• Advised the Danish State on multi-billion-euro acquisition of Copenhagen Airports
• Advised the Danish State on reorganisation of and investment in SAS AB
• Advised Hafnia on merger control and FDI related to acquisition of approx. 14% of the share capital in TORM
• Assisted Tryg with multi-billion-pound acquisition of parts of RSA Insurance Group
• Advised Uno-X and Reitan Convenience on re-acquisition and rebranding of 57 service stations from Shell
• Advised Circle K on acquisition of Shell's Danish business, including remedy divestment of 200+ service stations
• Advised Equinor on acquisition of BeGreen Solar
• Advised Equinor on acquisition of Danske Commodities
• Advised Arjun Infrastructure Partners on acquisition of Bigadan Holding
• Advised KMT Medical on call-in merger control process related to the divestment of Kirstine Hardam A/S
• Advised Zealand Pharma on license of CT-388 (obesity) to F Hoffmann-La Roche
• Advised Gubra on license of GUB014295 (obesity) to AbbVie
• Assisted LEO Pharma with merger control and FDI related to Nordic Capital partnership
• Advised Novonesis on sale of parts of its Lactase Enzymes Business to Kerry Group
• Advised Demant on sale of Oticon Medical's cochlear implant business to Cochlear 
• Advised Netcompany Group on acquisition of Skandinavisk Data Center (SDC)
• Advised Netcompany Group on establishment of Smarter Airports joint venture with Copenhagen Airports
• Advised Agilitas on acquisition of NNIT IO-business from NNIT (now Aeven) 
• Assisted Aeven on acquisition of KMD's infrastructure outsourcing business
• Advised Marlin Equity Partners on merger of transport management software providers Unifaun and Consignor
• Assisted Faerch in the acquisition of PACCOR, including EU and national merger control clearances
• Advised Faerch on acquisition of stakes and activities from Sirap Gema
• Advised Advent International Corporation on sale of Faerch Plast to A.P. Møller Holding
• Advised Sanistål on Ahlsell's takeover offer to Sanistål's shareholders
• Advised HKScan on divestment of Rose Poultry
• Advised EQT and Huscompagniet on the attempted acquisition of euro-Dan 
• Advised Gebr. Heinemann on travel retail shops concession agreement with Scandlines
• Advised Gebr. Heinemann on acquisition of part of TMC Nordic